OVERVIEW

Management of Advanced hepatocellular carcinoma (HCC) (On-demand) is organized by Society of Interventional Radiology (SIR).

Course Expires: Oct 27, 2020

Credits:
1.50 Self-Assessment CME
1.50 CME
1.50 Participation

Description:
Advanced HCC spans 10-20% of HCC diagnoses and is associated with poor outcomes. This session will focus on fundamental aspects of advanced HCC management relevant to IRs in practice, and the potential role of Precision Medicine initiatives in developing and improving treatments for this disease. This course is designed to educate and update IRs in advanced HCC epidemiology, classification, medical and locoregional therapy, and the evolving role for precision medicine in advanced HCC treatment.

This enduring activity is designed to meet the educational needs of interventional radiologists, IRs in training, nurses, physician assistants and other physicians at all levels with a special interest in oncologic interventions, embolization, and HCC.

After purchasing access to this educational activity, you will be directed to the SIR Learning Center to participate in the activity and obtain your certificate. To receive CME credit for this enduring activity, participants must watch the video and score 70% or better on the post-activity exam. Participants will have three opportunities to score 70% or better.

Learning Objectives:
Upon completion of this enduring activity, participants should be able to:
• Understand the benefits and limitations of the current HCC staging systems including the ECOG system.
• Describe the advantages and limitations of the IA and systemic therapies.
• Identify the alternatives for HCC with PVT.

Additional details will be posted as soon as they are available.